Veritas In Silico Inc (130A)

Tokyo
Currency in JPY
860.00
+40.00(+4.88%)
Closed
130A Scorecard
Full Analysis
Liquid assets exceed short term obligations
Fair Value
Day's Range
812.00900.00
52 wk Range
637.002,330.00
Key Statistics
Edit
Bid/Ask
843.00 / 860.00
Prev. Close
820
Open
814
Day's Range
812-900
52 wk Range
637-2,330
Volume
67.9K
Average Vol. (3m)
54.04K
1-Year Change
-46.95%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
130A Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Not profitable over the last twelve months
No news in this category
Looks like there are no results in this news category

Veritas In Silico Inc Company Profile

Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. It has strategic partnership with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. The company was incorporated in 2016 and is based in Shinagawa, Japan.

Compare 130A to Peers and Sector

Metrics to compare
130A
Peers
Sector
Relationship
P/E Ratio
−23.6x−10.3x−0.5x
PEG Ratio
0.03−0.220.00
Price / Book
-2.2x2.6x
Price / LTM Sales
28.7x3.0x3.0x
Upside (Analyst Target)
-56.9%53.8%
Fair Value Upside
Unlock5.6%9.2%Unlock

Earnings

Latest Release
Feb 13, 2025
EPS / Forecast
-14.11 / --
Revenue / Forecast
29.00M / --
EPS Revisions
Last 90 days

FAQ

What Is the Veritas In Silico (130A) Stock Price Today?

The Veritas In Silico stock price today is 860.00

What Stock Exchange Does Veritas In Silico Trade On?

Veritas In Silico is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Veritas In Silico?

The stock symbol for Veritas In Silico is "130A."

What Is the Veritas In Silico Market Cap?

As of today, Veritas In Silico market cap is 5.58B.

What is Veritas In Silico Earnings Per Share?

The Veritas In Silico EPS is -37.11.

What Is the Next Veritas In Silico Earnings Date?

Veritas In Silico will release its next earnings report on May 13, 2025.

From a Technical Analysis Perspective, Is 130A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.